ABSTRACT
Blood coagulation is a process describing conversion of soluble materials within the blood into an insoluble gel that plugs injury/break site within blood vessels; this process requires regulation. Diabetes mellitus is a metabolic disorder characterized by hyperglycemia, defectiveness of insulin hormone has been found to have an increased risk of coagulation and can lead to cardiovascular disorders. Malaria is a disease caused by plasmodium parasite, when the parasite enters the bloodstream; proteins are secreted into the host’s red blood cells, which stick to other blood cells making them adherent to blood vessel walls reducing detection and destruction of infected blood cells by the immune system which potentially causes blood clots. Effect of anti-malaria drugs on blood coagulation has not been properly investigated, as diabetics have been found to have possible co-infection with malaria, this study aims to provide information on the modulation of blood coagulation by metformin and artemether-lumefantrine in diabetic mice co-infected with malaria.
Fifty albino mice (BALB/C strain) were divided into 8 groups for this study; group I served as the normal control, group II served as diabetes negative control, group III served as malaria only, group IV served as diabetes co-infected with malaria group, group V served as malaria treated with 6.86 mg/body weight of artemether-lumefantrine, group VI served as diabetes treated with 200 mg/body weight of metformin, group VII served as diabetes co-infected malaria and treated with 200 mg/body weight of metformin and group VIII served as diabetes co-infected with malaria and treated with 200 mg/body weight of metformin and 6.86 mg/body weight of artemether-lumefantrine.
The results showed artemether-lumefantrine having an anti-coagulant effect on prothrombin time of extrinsic factors in malaria positive treatment group, metformin having a pro-coagulant effect on intrinsic factors in diabetes positive control group, and artemether-lumefantrine elevating the fibrinogen concentration in malaria positive control group. These findings suggest that while metformin is the first-line drug with an anti-coagulant effect on diabetes, artemether-lumefantrine not only could cure plasmodium falciparum but also possesses an anticoagulant effect.
Keywords: Artemether-Lumefantrine, Blood coagulation, Diabetes, Malaria, Metformin
ABSTRACT: Assessing the role of music therapy in early childhood education is c...
BACKGROUND OF THE STUDY
In fact many researches have been conducted in many countries, especially in Ni...
ABSTRACT
This study was carried out on assessing the health effect of pesticide exposure in agricultura...
BACKGROUND OF THE STUDY
Close to a decade after the inauguration of the Economic and Financial Crimes C...
This project was designed to research into the influence of home background on the academic performance of children in selecte...
Introduction and Background
Understanding the physics of our surrounding has driven science and technology for a long time and while some...
Abstract: The impact of entrepreneurship education on vocational students is essential for...
ABSTRACT: This study explores the benefits of early childhood education (E...
Abstract
Inspired by the rise of smaller computing devices and ubiquitous network connectivity, this dissertation focuses on the dynamics...
EXCERPT FROM THE STUDY
In essence, communication involves using codes that are done with the eyes, body movement or soun...